OraSure Technologies Inc (OSUR)
5.53
+0.18
(+3.36%)
USD |
NASDAQ |
Apr 23, 16:00
5.41
-0.12
(-2.17%)
Pre-Market: 08:29
OraSure Technologies SG&A Expense (Quarterly): 20.91M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 20.91M |
September 30, 2023 | 18.79M |
June 30, 2023 | 24.96M |
March 31, 2023 | 29.85M |
December 31, 2022 | 27.31M |
September 30, 2022 | 29.00M |
June 30, 2022 | 29.26M |
March 31, 2022 | 31.87M |
December 31, 2021 | 27.56M |
September 30, 2021 | 26.38M |
June 30, 2021 | 21.41M |
March 31, 2021 | 19.72M |
December 31, 2020 | 21.33M |
September 30, 2020 | 17.96M |
June 30, 2020 | 20.40M |
March 31, 2020 | 17.42M |
December 31, 2019 | 19.47M |
September 30, 2019 | 16.51M |
June 30, 2019 | 14.95M |
March 31, 2019 | 16.22M |
December 31, 2018 | 18.14M |
September 30, 2018 | 13.83M |
June 30, 2018 | 16.08M |
March 31, 2018 | 20.89M |
December 31, 2017 | 14.54M |
Date | Value |
---|---|
September 30, 2017 | 14.10M |
June 30, 2017 | 15.25M |
March 31, 2017 | 13.97M |
December 31, 2016 | 15.67M |
September 30, 2016 | 13.34M |
June 30, 2016 | 13.75M |
March 31, 2016 | 15.25M |
December 31, 2015 | 15.14M |
September 30, 2015 | 16.61M |
June 30, 2015 | 14.98M |
March 31, 2015 | 13.85M |
December 31, 2014 | 16.72M |
September 30, 2014 | 14.83M |
June 30, 2014 | 16.25M |
March 31, 2014 | 17.06M |
December 31, 2013 | 17.15M |
September 30, 2013 | 14.32M |
June 30, 2013 | 17.38M |
March 31, 2013 | 19.26M |
December 31, 2012 | 16.51M |
September 30, 2012 | 13.82M |
June 30, 2012 | 15.13M |
March 31, 2012 | 13.94M |
December 31, 2011 | 11.58M |
September 30, 2011 | 12.25M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
14.95M
Minimum
Jun 2019
31.87M
Maximum
Mar 2022
22.90M
Average
21.33M
Median
Dec 2020
SG&A Expense (Quarterly) Benchmarks
Abbott Laboratories | 2.959B |
Integra Lifesciences Holdings Corp | 163.13M |
Insulet Corp | 212.80M |
Perspective Therapeutics Inc | 1.694M |
Xtant Medical Holdings Inc | 20.45M |